Twitter board adopts poison pill as Musk takeover defense

Apr. 15, 2022 12:22 PM ETTwitter, Inc. (TWTR)By: Jason Aycock, SA News Editor508 Comments

Twitter Goes Public On The New York Stock Exchange

Andrew Burton/Getty Images News

  • Twitter (NYSE:TWTR) has adopted a shareholder rights plan - a "poison pill" designed to keep control in the company from being consolidated in the wake of Elon Musk's surprise effort to take control of the company.
  • The board unanimously adopted a shareholder rights plan similar to that at other companies, exercisable if any one entity acquires beneficial ownership of 15% or more of Twitter common stock in a transaction unapproved by the board.
  • In that event, the right will entitle other holders to purchase at a then-current exercise price more shares of common stock "having a "then-current market value of twice the exercise price of the right."
  • The plan has an expiration date of April 14, 2023.
  • Along with Musk, private-equity firm Thoma Bravo is reported to be taking a look at a rival bid for Twitter (TWTR).
  • At a Thursday afternoon all-hands meeting, Twitter (TWTR) CEO Parag Agrawal said the board was still evaluating Musk's $43 billion, $54.20/share offer to buy the company.
To ensure this doesn’t happen in the future, please enable Javascript and cookies in your browser.
Is this happening to you frequently? Please report it on our feedback forum.
If you have an ad-blocker enabled you may be blocked from proceeding. Please disable your ad-blocker and refresh.